In a significant development, U.S. District Judge J. Philip Calabrese has denied the majority of a motion to dismiss filed by Suboxone manufacturer Indivior Inc., allowing the failure to warn claims and a majority of the design defect claims to proceed. This ruling, issued on December 31, 2024, advances the multidistrict litigation (MDL) concerning the… Read More
Firm News
Helping Stone Industry Workers Affected by Silica Dust Exposure
Our law firm is investigating cases involving silicosis, pulmonary diseases, and autoimmune diseases caused by workplace silica dust exposure. These cases primarily affect workers who make, finish, or install stone products, as well as sandblasters, miners, masons, rock drillers, and glass manufacturers. In recent years, numerous people who make, finish, or install stone countertop products… Read More
Implanted Port Catheters and PowerPort Litigation
Medical device manufacturers produce a variety of implantable products, including the Bard PowerPort or port-a-cath, which are also known as injection ports and implanted port catheters. These devices are designed to provide long-term access to the bloodstream for patients who need frequent injections or infusions of medications, fluids, or blood products.
Class Action Filed Against Sweetwater Union High School District Over Data Breach
If you are a current or former employee or student, or their spouse, dependent, or family member, associated with Sweetwater Union High School District (SUHSD), you might have received one or more letters notifying you that your personal information may have been stolen in a cyberattack that occurred in February 2023.
Philips CPAP Recall
Due to potential chemical exposure, Royal Philips recalled several million CPAP (Continuous Positive Airway Pressure) machines and mechanical ventilator devices.
The Off-Label Use and Marketing of Amiodarone
The pharmaceutical industry’s off-label use and marketing of drugs is a massive driver of corporate profits.
Amiodarone Lawsuit News: The Strange History of Amiodarone
Amiodarone is the only drug in modern FDA history to be approved in the United States without undergoing the required randomized clinical studies to show a drug is safe and effective before it is approved.
Doyle APC Files First Class Action Against Intel For CPU Security Flaw
On January 3, 2018, after The Register broke the news of massive security vulnerabilities in all of Intel’s CPUs since 2004, Doyle APC filed the first class action complaint against Intel Corporation for damages caused by these security defects.